[go: up one dir, main page]

FR3023718B1 - Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression - Google Patents

Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression Download PDF

Info

Publication number
FR3023718B1
FR3023718B1 FR1456813A FR1456813A FR3023718B1 FR 3023718 B1 FR3023718 B1 FR 3023718B1 FR 1456813 A FR1456813 A FR 1456813A FR 1456813 A FR1456813 A FR 1456813A FR 3023718 B1 FR3023718 B1 FR 3023718B1
Authority
FR
France
Prior art keywords
decontaminated
pharmaceutical
high pressure
cosmetic compositions
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1456813A
Other languages
English (en)
Other versions
FR3023718A1 (fr
Inventor
Jean Francois Codoliani
Valerie Muguet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR1456813A priority Critical patent/FR3023718B1/fr
Priority to PCT/EP2015/066328 priority patent/WO2016008999A1/fr
Publication of FR3023718A1 publication Critical patent/FR3023718A1/fr
Application granted granted Critical
Publication of FR3023718B1 publication Critical patent/FR3023718B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
FR1456813A 2014-07-16 2014-07-16 Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression Active FR3023718B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1456813A FR3023718B1 (fr) 2014-07-16 2014-07-16 Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression
PCT/EP2015/066328 WO2016008999A1 (fr) 2014-07-16 2015-07-16 Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1456813 2014-07-16
FR1456813A FR3023718B1 (fr) 2014-07-16 2014-07-16 Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression

Publications (2)

Publication Number Publication Date
FR3023718A1 FR3023718A1 (fr) 2016-01-22
FR3023718B1 true FR3023718B1 (fr) 2018-10-12

Family

ID=51610329

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1456813A Active FR3023718B1 (fr) 2014-07-16 2014-07-16 Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression

Country Status (2)

Country Link
FR (1) FR3023718B1 (fr)
WO (1) WO2016008999A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3090385B1 (fr) 2018-12-21 2021-01-08 Pf Medicament Composition émolliente sous forme d’émulsion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
MXPA03009484A (es) * 2001-04-17 2004-02-12 Tanabe Seiyaku Co Agente preventivo/de remedio para enfermedades inflamatorias en la mucosa de la cavidad oral y lo similar.
FR2838969B1 (fr) * 2002-04-30 2006-05-19 Ellipse Pharmaceuticals Procede de sterilisation par haute pression de compositions pharmaceutiques sous forme micro ou nanodispersee et compositions ainsi obtenues
US20070293441A1 (en) * 2003-09-22 2007-12-20 Baxter International Inc. High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
CN1905905B (zh) * 2003-09-22 2011-06-08 巴克斯特国际公司 用于药物制剂和医药产品最终灭菌的高压灭菌
CA2600460A1 (fr) * 2005-03-08 2006-09-14 Fonterra Co-Operative Group Limited Traitement sous haute pression d'un complexe ions metalliques-lactoferrine
CN103040849A (zh) * 2011-10-12 2013-04-17 新乡医学院 一种治疗烧伤、褥疮和尿布皮炎的鞣酸制剂及制备方法
WO2013114004A1 (fr) * 2012-01-31 2013-08-08 Pierre Fabre Dermo-Cosmetique Composition et association de filtres solaires photostabilisatrices de bmdbm
FR3010634A1 (fr) * 2013-09-13 2015-03-20 Pf Medicament Compositions pharmaceutiques a base de tensioactif vegetal pour le traitement de l'hyposialie

Also Published As

Publication number Publication date
WO2016008999A1 (fr) 2016-01-21
FR3023718A1 (fr) 2016-01-22

Similar Documents

Publication Publication Date Title
EP3493799A4 (fr) Composition pharmaceutique decannabis
BR112016022062A2 (pt) Combinação, composição farmacêutica, uso de uma combinação ou de uma composição farmacêutica, e, produto farmacêutico
IL249061B (en) Combination, composition, and method of administering the combination or composition to animals
EP3139920A4 (fr) Composés anti-viraux, compositions pharmaceutiques et méthodes d'utilisation de ceux-ci
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
EP3476386C0 (fr) Composition pharmaceutique liquide
EP3493798A4 (fr) Composition pharmaceutique decannabis
HRP20181534T1 (hr) Novi spojevi kao inhibitori histonske deacetilaze 6 i farmaceutski pripravci koji ih sadrže
EP3454899C0 (fr) Composition pharmaceutique
DK3253382T3 (da) Farmaceutiske sammensætninger til kombinationsterapi
EP3364944C0 (fr) Compositions pharmaceutiques d'il-2
MA50541A (fr) Formulations pharmaceutiques
MA54716A (fr) Réduction de la viscosité de formulations pharmaceutiques
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
MA43705A (fr) Formulation pharmaceutique
BR112016021034A2 (pt) Composição farmacêutica, uso de tal composição, método para tratar uma doença e kit
MA42303A (fr) Formulations pharmaceutiques
EP3297640A4 (fr) Composition pharmaceutique à base de co-cristaux et son utilisation
IL248785B (en) Antecedents of ]-n5,1-dimethyl3--oxo-(3,2-dihydro-h1-pyrazol-4-yl)]-methyl-isoxazole-3-carboxamide and pharmaceutical preparations including these antecedents
DK3236934T3 (da) Farmaceutisk sammensætning, fremstilling og anvendelser deraf
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
MA47516A (fr) Composition pharmaceutique
EP3285758A4 (fr) Composition de co-cristaux et son utilisation pharmaceutique
EP3383371A4 (fr) Formulation pharmaceutique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160122

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12